MEA Research Review: Altered Endothelial Function in ME/CFS Blood Plasma
MEA Research Review: Altered Endothelial Function in ME/CFS Blood Plasma Read More »
A recent publication by Blauensteiner et al. based in Austria […]
Research Reviews
MEA Summary Review: Is mystery factor in plasma causing viral immunity in ME/CFS? | 06 May 2020
“This provides an explanation for the common observation that ME/CFS patients often report a sharp decrease in the number of colds and other viral infections they experience…”
MEA Summary Review: Assessing diagnostic value of microRNAs from PMBC’s and EV’s in ME/CFS | 11 February 2020
People with severe M.E. demonstrate low levels of Creatine Phosphokinase in study using samples from ME Biobank.
MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019
MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019 Read More »
We have updated this research review to include a new study from Finland.
MEA Summary Review: Differentiating Medical Uncertainty | 21 October 2019
MEA Summary Review: Differentiating Medical Uncertainty | 21 October 2019 Read More »
We take a closer look at recent research from America that highlights concerns over inappropriate and harmful labelling and advocates for medicine to adopt a more patient-centred approach to care.
MEA Summary Review: The Role of Mitochondria in ME/CFS | 13 July 2019
MEA Summary Review: The Role of Mitochondria in ME/CFS | 13 July 2019 Read More »
This latest review looks at energy production, and the ongoing search for clues as to what might be causing problems in ME/CFS.
MEA Summary Review: A Critique of the CBT Model in ME/CFS by Dr Keith Geraghty | 27 April 2019
“There is little scientific credibility in the claim that the psycho-behavioural therapies should be primary treatments for this illness.”
MEA Summary Review: UK ME Biobank – MAIT Cells are Increased in Severe ME/CFS | 16 April 2019
We discuss what the new research means and how the Biobank contribution continues to evolve.
MEA Summary Review: Assessing PEM – The characteristic symptom of ME/CFS | 25 March 2019
MEA Summary Review: Assessing PEM – The characteristic symptom of ME/CFS | 25 March 2019 Read More »
Latest research analysis is hoped will lead to a definitive definition and will ultimately provide a validated clinical assessment tool.
ME/CFS researcher Dr Cara Tomas explains the results from a new study on energy production and mitochondria | 14 March 2019
Abnormalities in energy production would seem to occur ‘upstream’ of the mitochondria.
MEA Summary Review: Metabolites from ME/CFS implicate ‘Redox’ imbalance | 02 February 2019
Evidence could support the involvement of oxidative stress, inflammation and hypoxia in ME/CFS.
MEA Summary Review: US study of onset patterns and course of illness in ME/CFS | 29 January 2019
Epidemiology studies are few and far between in the field of ME/CFS.
MEA Summary Review: Study suggests brain inflammation in ME/CFS | 15 January 2019
MEA Summary Review: Study suggests brain inflammation in ME/CFS | 15 January 2019 Read More »
The latest study from Jarred Younger reports on brain temperature and neuroinflammation in ME/CFS.
MEA Summary Review: Cardiac abnormalities in ME/CFS not due to deconditioning | 26 November 2018
A large replication that used tilt table testing and rejected the interpretation of an earlier study.
MEA Summary Review: The search for biomarkers in ME/CFS using Raman spectroscopy | 06 September 2018
Charlotte explains the methods and results from this latest research from Dr Morten’s team in Oxford.
MEA Summary Review: Natural Killer Cells as a Biomarker in ME/CFS | 17 August 2018
MEA Summary Review: Natural Killer Cells as a Biomarker in ME/CFS | 17 August 2018 Read More »
A recent study from Spain has prompted this review of NK cell involvement in ME/CFS.
MEA Research Update: Metabolomics and ME/CFS – Dr Morten and the Oxford research centre | 13th August 2018
In this update we learn about metabolomics and its importance for ME/CFS biomarker discovery, and how research at Oxford is progressing.
MEA Summary Review: ME/CFS and the Biopsychosocial Model – By Dr Keith Geraghty | 29 June 2018
In a guest review, Dr Geraghty summarises his most recent study examining the BPS model in ME/CFS
MEA Summary Review: Elevated BNP levels in ME/CFS associate with cardiac dysfunction | 14 February 2018
A recent study from a research group at Newcastle University has found that patients with ME/CFS have significantly higher levels of a hormone called BNP in their blood and that this also correlated with significantly lower cardiac volumes.